US Stock MarketDetailed Quotes

SER Serina Therapeutics

Watchlist
  • 7.140
  • -0.390-5.17%
Close Aug 9 16:00 ET
60.08MMarket Cap-119000P/E (TTM)

Serina Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
Total revenue
0
0
0
0
-83.55%500K
3.04M
Operating revenue
--0
--0
--0
--0
-83.55%500K
--3.04M
Cost of revenue
Gross profit
Operating expense
309.10%3.87M
141.27%2.32M
945K
962K
-40.69%2.77M
4.67M
Selling and administrative expenses
391.12%2.32M
105.73%1.22M
--473K
--593K
-0.68%1.29M
--1.3M
-General and administrative expense
391.12%2.32M
105.73%1.22M
--473K
--593K
-0.68%1.29M
--1.3M
Research and development costs
232.78%1.59M
177.19%1.11M
--479K
--399K
-58.59%1.57M
--3.8M
Other operating expenses
-628.57%-51K
83.33%-5K
---7K
---30K
78.50%-91.5K
---425.57K
Operating profit
-309.10%-3.87M
-141.27%-2.32M
-945K
-962K
-39.16%-2.27M
-1.63M
Net non-operating interest income expense
-124.07%-242K
-15.12%-99K
-108K
-86K
-281.85%-14.12K
7.77K
Non-operating interest income
----
----
----
----
-83.82%1.76K
--10.86K
Non-operating interest expense
124.07%242K
15.12%99K
--108K
--86K
413.19%15.88K
--3.09K
Other net income (expense)
398.93%9.29M
-359.31%-7.02M
1.86M
2.71M
-210.75%-397.62K
359.04K
Gain on sale of security
399.41%9.29M
-359.31%-7.02M
--1.86M
--2.71M
-300.52%-398.7K
--198.84K
Special income (charges)
----
----
----
----
--0
--160.21K
-Less:Other special charges
----
----
----
----
----
---187.13K
-Gain on sale of business
----
----
----
----
--0
---26.93K
Other non- operating income (expenses)
---9K
----
----
----
--1.08K
----
Income before tax
540.72%5.18M
-669.18%-9.44M
808K
1.66M
-112.07%-2.68M
-1.26M
Income tax
Net income
540.72%5.18M
-669.18%-9.44M
808K
1.66M
-112.07%-2.68M
-1.26M
Net income continuous Operations
540.72%5.18M
-669.18%-9.44M
--808K
--1.66M
-112.07%-2.68M
---1.26M
Minority interest income
-27K
0
Net income attributable to the parent company
544.06%5.2M
-669.18%-9.44M
808K
1.66M
-112.07%-2.68M
-1.26M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
544.06%5.2M
-669.18%-9.44M
808K
1.66M
-112.07%-2.68M
-1.26M
Basic earnings per share
63.60%0.61
-538.96%-3.38
0.3729
0.77
-112.07%-1.2377
-0.5836
Diluted earnings per share
426.53%0.51
-1,790.00%-3.38
0.0969
0.2
-112.07%-1.2377
-0.5836
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021
Total revenue 0000-83.55%500K3.04M
Operating revenue --0--0--0--0-83.55%500K--3.04M
Cost of revenue
Gross profit
Operating expense 309.10%3.87M141.27%2.32M945K962K-40.69%2.77M4.67M
Selling and administrative expenses 391.12%2.32M105.73%1.22M--473K--593K-0.68%1.29M--1.3M
-General and administrative expense 391.12%2.32M105.73%1.22M--473K--593K-0.68%1.29M--1.3M
Research and development costs 232.78%1.59M177.19%1.11M--479K--399K-58.59%1.57M--3.8M
Other operating expenses -628.57%-51K83.33%-5K---7K---30K78.50%-91.5K---425.57K
Operating profit -309.10%-3.87M-141.27%-2.32M-945K-962K-39.16%-2.27M-1.63M
Net non-operating interest income expense -124.07%-242K-15.12%-99K-108K-86K-281.85%-14.12K7.77K
Non-operating interest income -----------------83.82%1.76K--10.86K
Non-operating interest expense 124.07%242K15.12%99K--108K--86K413.19%15.88K--3.09K
Other net income (expense) 398.93%9.29M-359.31%-7.02M1.86M2.71M-210.75%-397.62K359.04K
Gain on sale of security 399.41%9.29M-359.31%-7.02M--1.86M--2.71M-300.52%-398.7K--198.84K
Special income (charges) ------------------0--160.21K
-Less:Other special charges -----------------------187.13K
-Gain on sale of business ------------------0---26.93K
Other non- operating income (expenses) ---9K--------------1.08K----
Income before tax 540.72%5.18M-669.18%-9.44M808K1.66M-112.07%-2.68M-1.26M
Income tax
Net income 540.72%5.18M-669.18%-9.44M808K1.66M-112.07%-2.68M-1.26M
Net income continuous Operations 540.72%5.18M-669.18%-9.44M--808K--1.66M-112.07%-2.68M---1.26M
Minority interest income -27K0
Net income attributable to the parent company 544.06%5.2M-669.18%-9.44M808K1.66M-112.07%-2.68M-1.26M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 544.06%5.2M-669.18%-9.44M808K1.66M-112.07%-2.68M-1.26M
Basic earnings per share 63.60%0.61-538.96%-3.380.37290.77-112.07%-1.2377-0.5836
Diluted earnings per share 426.53%0.51-1,790.00%-3.380.09690.2-112.07%-1.2377-0.5836
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg